Monocyte-derived macrophages from Crohn's disease patients are impaired in the ability to control intracellular adherent-invasive Escherichia coli and exhibit disordered cytokine secretion profile

J Crohns Colitis. 2015 May;9(5):410-20. doi: 10.1093/ecco-jcc/jjv053. Epub 2015 Mar 24.

Abstract

Background: Ileal lesions of Crohn's disease [CD] patients are colonised by adherent-invasive Escherichia coli [AIEC] able to survive in macrophage cell lines. We analysed the ability of monocyte-derived macrophages [MDM] from CD patients to control AIEC intracellular replication and the pro-inflammatory cytokine response of the infected-MDM.

Methods: Peripheral blood MDM were obtained from 24 CD genotyped for NOD2 and ATG16L1 mutations, 5 ulcerative colitis [UC] patients and 12 healthy controls [HC]. The numbers of intracellular bacteria were determined using gentamicin assay. Cytokine secretion was quantified by ELISA assay.

Results: We observed that higher levels of bacteria were internalised within MDM from CD patients than MDM from HC or UC patients. MDM from CD patients were unable to restrict AIEC intracellular replication. Infection of MDM from CD patients with AIEC resulted in significantly increased secretion of IL-6 and tumour necrosis factor alpha [TNF α] than did infection with non-pathogenic E. coli. AIEC-infected MDM from CD patients exhibited a disordered cytokines secretion compared with MDM from UC patients and HC. AIEC-infected MDM from patients with quiescent CD released significantly higher amounts of IL-6 and TNF-alpha than those with active disease or those from HC. The level of secreted TNF-alpha was correlated to the number of intracellular AIEC in MDM from CD patients. Treatment of MDM with infliximab did not change the MDM behaviour.

Conclusions: MDM from CD patients are unable to restrict intracellular AIEC replication, leading to disordered inflammatory response influenced by disease activity.

Keywords: Crohn’s disease; Macrophages; adherent-invasive E. coli; cytokines; infliximab.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Anti-Inflammatory Agents, Non-Steroidal / pharmacology
  • Autophagy-Related Proteins
  • Bacterial Adhesion / immunology
  • Bacterial Load / drug effects
  • Carrier Proteins / genetics
  • Cells, Cultured
  • Colitis, Ulcerative / immunology*
  • Colitis, Ulcerative / microbiology
  • Crohn Disease / genetics
  • Crohn Disease / immunology*
  • Crohn Disease / microbiology
  • Escherichia coli / growth & development*
  • Escherichia coli / isolation & purification
  • Escherichia coli Infections / immunology*
  • Female
  • Genotype
  • Humans
  • Infliximab / pharmacology
  • Interleukin-6 / metabolism
  • Interleukin-8 / metabolism
  • Macrophages / immunology*
  • Macrophages / metabolism*
  • Macrophages / microbiology
  • Male
  • Middle Aged
  • Nod2 Signaling Adaptor Protein / genetics
  • Polymorphism, Single Nucleotide
  • Tumor Necrosis Factor-alpha / metabolism

Substances

  • ATG16L1 protein, human
  • Anti-Inflammatory Agents, Non-Steroidal
  • Autophagy-Related Proteins
  • Carrier Proteins
  • Interleukin-6
  • Interleukin-8
  • NOD2 protein, human
  • Nod2 Signaling Adaptor Protein
  • Tumor Necrosis Factor-alpha
  • Infliximab